acculis-accu2i-applicator

Register to receive a free US Interventional Oncology Device Market Report Suite synopsis and brochure

According to a new series of reports on the US market for interventional oncology devices by iData Research, the cancer tumor ablation device market is expected to exhibit ongoing growth due to a shift towards newer and more expensive procedures. As cancer rates continue to rise in the aging US population, the substantial increase in the patient base drives surgeons to resort to tumor ablation in order to reduce post-surgical discomfort in patients. Tumor ablation alleviates many of the problems associated with open surgical procedures such as risk of infection and scarring, while accelerating recovery time.

This market expansion has primarily been the result of growth in ablation probe sales across the three different modalities: cryoablation, microwave ablation and radio frequency ablation (RFA). AngioDynamics is the leader in the tumor ablation device market with their popular StarBurst® radio RFA portfolio accounting for over half of the entire RFA market. AngioDynamics’ acquisition of Microsulis Medical in 2013 added the Acculis® microwave ablation system to their portfolio, which continues to make inroads in the oncology device market.

Similar to AngioDynamics, Covidien is a major competitor in the tumor ablation device market, capturing nearly one-third of the overall market. The new microwave Emprint® and RFA systems are gaining market share. In order to remain competitive, AngioDynamics has introduced its NanoKnife® system, a product that uses a completely different type of technology known as irreversible electroporation ablation, and it has received FDA clearance to market this product.

“Success in the ablation market will be achieved by selling more than one ablation modality,” explains Dr. Kamran Zamanian, CEO of iData. “However, radio frequency ablation has been established as a standard of care in the tumor ablation space and will continue to maintain notable procedural volume and market share for many years to come.”

In the US, there are approximately 600 facilities that offer tumor ablation treatments. While some sites may have all three types of ablation capabilities, many only have one. Despite the number of ablation sites available, approximately 80% of all tumor ablation procedures are performed by the top 30% of facilities. Large-scale, high-volume facilities receive substantial discounts in their purchases of both disposables and capital equipment. Many facilities also receive capital equipment royalty-free in exchange for buying a certain amount of disposables per annum.

For Further Information
More on the oncology device market in the US can be found in a report suite published by iData Research entitled the US Interventional Oncology Market Report Suite. The suite covers reports on the following markets: External Radiation Therapy Device Market, Internal Radiation Therapy Device Market, Ablation Device Market, Embolization Particle Market, and Cancer Procedures and Incidence Rates.

Reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about oncology device market data or procedure data, register online or email us at [email protected] for a US Interventional Oncology Market Report Suite brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch